secwatch.observer — SEC 8-K summary
======================================

Issuer:     REPLIGEN CORP (RGEN)
CIK:        0000730272
Form:       8-K
Filed at:   2023-04-18T23:59:59+00:00
Accession:  0001193125-23-104254
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Repligen completes acquisition of FlexBiosys Inc. on April 17, 2023
-------------------------------------------------------------------

- Completed acquisition of all outstanding equity of FlexBiosys Inc. on April 17, 2023.
- Equity Purchase Agreement signed April 12, 2023, with sellers TSAP Holdings, Gayle Tarry, and Stanley Tarry.
- No deal value or financial terms disclosed in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730272/000119312523104254/0001193125-23-104254-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730272/000119312523104254/d464614d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-104254

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer